Characterization of Plasmid-Mediated β-Lactamases in Fecal Colonizing Patients in the Hospital and Community Setting in Spain
- 1 August 2014
- journal article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 20 (4) , 301-304
Abstract
Aim: Active surveillance of plasmid-mediated β-lactamase-producing Enterobacteriaceae (PMBL-E) in fecal carriers in the hospital and in the community setting in a non-outbreak period of time. Methods: Patients were screened for carriage of Enterobacteriaceae resistant to expanded-spectrum cephalosporins and PMBL-E were characterized (extended-spectrum-β-lactamase [ESBL], plasmid-mediated AmpC β-lactamase [pAmpC], and carbapenemases) by PCR and sequencing. Results: The prevalence of ESBL and pAmpC carriers was 5.06% and 0.59%, respectively. Overall, CTX-M-like enzymes were the ESBL dominate enzymes (96.15%). The group CTX-M-9 was the most prevalent (81, 54%) [CTX-M-14 (74, 91.35%), CTX-M-9 (5, 6.17%), CTX-M-24 (1, 1.23%), and CTX-M-27 (1, 1.23%)] followed by the group CTX-M-1 (64, 42.67%) [CTX-M-15 (42, 65.63%), CTX-M-1 (13, 20.31%), CTX-M-32 (8, 12.5%), and CTX-M-3 (1, 1.56%)]. One CTX-M-10, one CTX-M-59, and three CTX-M-8 were also found. A very small representation of SHV or TEM ESBL enzymes was found (3.2% and 0.64%, respectively). pAmpC characterization revealed a predominance of CMY-2 (81.25%), followed by DHA-1 (18.75%). We did not detect the presence of carbapenemase producers. Conclusions: The prevalence of ESBL-producers from fecal carriers is stable in our area, but colonization by pAmpC producers has emerged recently as we have confirmed. Periodic active surveillance is useful to identify these human reservoirs and control the evolution of PMBL carriage in a community over time.Keywords
This publication has 19 references indexed in Scilit:
- Molecular epidemiology, resistance profiles and clinical features in clinical plasmid-mediated AmpC-producing EnterobacteriaceaeInternational Journal of Medical Microbiology, 2013
- CTX-M-type β-lactamases: A successful story of antibiotic resistanceInternational Journal of Medical Microbiology, 2013
- Appropriateness of Empirical Treatment and Outcome in Bacteremia Caused by Extended-Spectrum-β-Lactamase-Producing BacteriaAntimicrobial Agents and Chemotherapy, 2013
- Clonal Structure, Extended-Spectrum β-Lactamases, and Acquired AmpC-Type Cephalosporinases of Escherichia coli Populations Colonizing Patients in Rehabilitation Centers in Four CountriesAntimicrobial Agents and Chemotherapy, 2013
- Fecal Carriage of Carbapenemase-Producing Enterobacteriaceae: a Hidden Reservoir in Hospitalized and Nonhospitalized PatientsJournal of Clinical Microbiology, 2012
- Evaluation of four phenotypic methods to detect plasmid-mediated AmpC β-lactamases in clinical isolatesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012
- Diversity of Escherichia coli Strains Producing Extended-Spectrum β-Lactamases in Spain: Second Nationwide StudyJournal of Clinical Microbiology, 2010
- Outbreak of CTX-M-15-Producing Klebsiella pneumoniae in the Intensive Care Unit of a French HospitalMicrobial Drug Resistance, 2009
- Characterization of CTX-M and SHV extended-spectrum -lactamases and associated resistance genes in Escherichia coli strains of food samples in TunisiaJournal of Antimicrobial Chemotherapy, 2007
- Prevalence of fecal carriage of ESBL-producing Enterobacteriaceae in hospitalized and ambulatory patients during two non-outbreak periodsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006